Investigational Site Number 642007

Bucharest 020475

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Type 2 Diabetes

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM — Completed